Interpretation of the updated NCCN clinical practice guidelines in oncology:Non-small cell lung cancer(version 5.2024)
Lung cancer is the leading cause of cancer-related deaths worldwide,especially non-small cell lung cancer(NSCLC).With the popularization of low-dose CT and the improvement of people's awareness of physical examinations,the number of detected pulmonary nodules is gradually increasing,and there is a greater demand for standardized diagnostic and treatment guidelines.On April 23,2024,the National Comprehensive Cancer Network updated its clinical practice guidelines for NSCLC to the version 5.Compared with the version 5 in 2023,the version 5 in 2024 updates focus on diagnostic evaluation,perioperative systemic therapy,treatment of advanced NSCLC,and molecular marker testing,which will be interpreted in this article with the aim of providing the latest guidance and reference for the diagnosis and treatment of lung cancer in China.
NETL
NSTL
万方数据
